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Abstract
Background: Resistances to currently available drugs and insecticides, significant drug toxicities and costs and
lack of vaccines currently complicated the treatment of malaria. A continued search for safe, effective and
affordable plant-based antimalarial agents thus becomes crucial and vital in the face of these difficulties. The
aim of the study was to evaluate the antimalarial activity of 80 % methanolic extract of the seeds of Brassica
nigra against Plasmodium berghei infection in mice.
Method: Chloroquine sensitive Plasmodium berghei (ANKA strain) was used to test the antimalarial activity of the
extract. In suppressive and prophylactic models, Swiss albino male mice were randomly grouped into five groups of five
mice each. Group I mice were treated with the vehicle, group II, III and IV were treated with 100, 200, and 400 mg/kg of
the extract, respectively and the last group (V) mice were treated with chloroquine (10 mg/kg). The level of parasitemia,
survival time and variation in weight of mice were used to determine the antimalarial activity of the extract.
Results: Chemosuppressive activities produced by the extract of the seeds of Brassica nigra were 21.88, 50.00 (P < 0.01)
and 53.13 % (P < 0.01), while the chemoprophylactic activities were 17.42, 21.21 and 53.79 % (P < 0.05) at 100, 200 and
400 mg/kg of the extract, respectively as compared to the negative control. Mice treated with 200 and 400 mg/kg extract
were significantly (P < 0.05) lived longer and gained weight as compared to negative control in 4-day suppressive test.
Conclusion: From this study, it can be concluded that the seed extract of Brassica nigra showed good chemosuppressive
and moderate chemoprophylactic activities and the plant may contain biologically active principles which are relevant in
the treatment and prophylaxis of malaria, thus supporting further studies of the plant for its active components.
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Background
Malaria is a serious hazard to humanity and the major
cause of mortality and morbidity in the malaria-endemic
countries. Even though the distribution of the disease is
substantially varied, sub-Saharan Africa, Asia and Central
and Latin America are the most affected regions. About
50 % of populations in the world live in malaria risk areas.
In 2013, it was estimated that 198 million cases of malaria
and 584,000 malarial deaths have been occurred in the
world. The burden of the disease is heaviest in Africa,
where 82 and 90 % of all global cases and deaths were oc-
curred, respectively [1].
Resistances of mosquitoes to insecticides and parasites to
antimalarial drugs especially to the current most effective
and newest artemisinin derivatives have led to an increase
in severe malaria and complicate the eradication of the dis-
ease as well as the resurgence of malaria [2]. While there is
much need and there is currently no alternative to the pre-
cious artemisinin derivatives, the antimalarial drug develop-
ment pipeline remains sadly thin with little chemical
diversity [3]. Preventive and treatment strategies of malaria
are not only continuously hampered by the issues of resist-
ance but also considerable costs and logistical problems
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especially in poor malarious countries as well as a challenge
of having effective vaccines create a great and urgent con-
cern for the treatment of the disease [4].
Additionally, many antimalarial drugs in use today have
high toxicity and low therapeutic margin of indices that ex-
poses patients’ additional harm and health expenditure [5].
The efficacy, safety and quality of most medicinal plant prod-
ucts in traditional medicine are not validated and standard-
ized. Medicinal plants used in traditional medicine should,
therefore, be studied for their safety and efficacy and their
quality as well to safe guard the health of customers [6].
In the face of current resistance problems, medicinal
plants are a potential source of new, effective and afford-
able antimalarial agents. However, most of these plants,
represent a virtually unlimited reservoir of molecules, are
not explored chemically and can constitute lead molecules
for development of new antimalarial drugs. Therefore, anti-
malarial drug discovery from such plants is currently more
targeted because histories proved that plants are richest
sources of antimalarial phytochemicals [7, 8].
Quinine and artemisinin, two main classes of antimalar-
ials, currently in use have been provided by Cinchona spe-
cies and Artemisia annua traditionally used for malaria for
a long period of times, respectively. Therefore, medicinal
plants have made and continue to make a great contribu-
tion to antimalarial chemotherapy as they contain mole-
cules with a great variety of structures and biological
activities [9, 10].
The genus Brassica is reported to comprise over 150
species, of which five including Brassica nigra are found
in Ethiopian flora. Brassica nigra (local Ethiopian Amharic
name: Senafitch) is an annual, erect, aromatic, up to
100 cm tall with freely and widely branching, and gla-
brate weedy herb [11]. Brassica nigra is used throughout
the world for various aspects such as food, vegetable, medi-
cinal and industrial products. The medicinal effect is mainly
confined to its seeds. The seeds have been used as tonic, di-
gestive, emetic, appetite stimulant, laxatives, antiseptics and
for carcinoma and tumors [12], liver and spleen indura-
tions, abscesses, colds, headaches, rheumatism, edema,
neuralgia, alopecia, epilepsy, snakebite, toothache, hiccup,
pneumonia [13] and malaria [14, 15]. Its seeds are pow-
dered and a paste have been made with water and then
eaten with and without “Injera” (a flat Ethiopian bread re-
sembling a large pancake) for the prevention and treat-
ment of malaria, respectively, in Ethiopia [15].
The seed extract of Brassica nigra showed potent anti-
epileptic activity [16] which might be important for the
management of cerebral malaria which is associated with
protracted and/or febrile convulsions. The plant is also
endowed with various pharmacologically active phyto-
chemicals, such as alkaloids, flavonoids, tannins, terpe-
noids, and others [17, 18], with reported antiplasmodial
activity [10] and hence this also justified the current study.
Considering all the above since there is no previous re-
port, laboratory-based evidence for its antimalarial ef-
fectiveness is found essential. This study is, therefore,
designed to evaluate the antimalarial activity of the 80 %
methanolic extract of the seeds of Brassica nigra against
Plasmodium berghei infection in mice.
Methods
Collection and preparation of the plant materials
The fresh seeds of Brassica nigra were collected from the
farmers’ farmland in November 2014, around Gondar town,
728 km from Addis Ababa, Northwest Ethiopia. The plant
was identified and authenticated and a voucher specimen
(with a voucher number of AB05) was deposited at Na-
tional Herbarium, Addis Ababa University, Ethiopia. The
seeds of Brassica nigra were cleaned and air-dried in the
shade at room temperature. The dried seeds were coarsely
powdered using mortar and pestle. Then the powdered
plant materials were stored in a plastic container and they
were kept at room temperature until extraction.
Extraction of the plant materials
The powdered samples of seeds of B. nigra (325 g) were
weighed by sensitive balance. They were extracted by ma-
ceration with 80 % methanol (1:10 ratio of powdered plant
material (in gram) and solvent (in millitre), respectively)
for three consecutive days with occasional stirring. After
72 h, the mixture was filtered with Whatman filter paper
no 1 (Whatman, England). The residue was re-macerated
twice for the same duration of hours and then the mixture
were filtered [19]. The combined filtrates were dried by
oven (250 V, France) set below 40 °C. The weight of the
dried extract was measured to determine the percentage
yield. Finally, the dried extract was then transferred into a
vial and it was kept in a refrigerator until further use.
Experimental animals
Fifty Swiss albino male mice, weighing 25 to 32 g and 6
to 8 weeks old inbred at the Animal House of the De-
partment of Pharmacology, University of Gondar were
used. They were housed in plastic cages with softwood
shavings and chips as beddings. They were exposed to a
12:12 dark-to-light cycle. They had free access to pellet
diet and clean drinking water. All mice were acclima-
tized to the working environment one week before the
beginning of the experiment [20].
Parasites
Chloroquine sensitive Plasmodium berghei (ANKA strain)
was used for induction of malaria in experimental mice.
Mice previously infected with P. berghei were used as
donor. The donor P. berghei infected mice were obtained
from Aklilu Lemma Institute of Pathobiology, Addis Ababa
University, Ethiopia. The parasites were subsequently
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maintained in the laboratory by serial passage of blood
from donor infected mice to naive one via intra-peritoneal
(IP) route on weekly basis [21].
Drugs and reagents
Chloroquine (Addis Pharmaceuticals Factory, Ethiopia),
methanol (Okhla Industrial, India), Giemsa (Sciencelab,
USA), trisodium citrate (Deluxe Scientific surgico, India),
ketamine (Rotexmedica, Germany) and normal saline
(Addis Pharmaceuticals Factory, Ethiopia) were used.
All reagents were analytically graded and procured from
certified suppliers.
Study design and sampling method
Experimental study design was used. Simple random sam-
pling technique was employed for grouping of experimen-
tal animals and assignments of treatments.
Inoculum preparation
The parasitemia of the previously P. berghei infected
donor mouse were determined. After anaesthetizing with
ketamine, the blood from these mice was collected via car-
diac puncture with a rising parasitaemia of 30 to 35 % into
a test tube having 0.5 % trisodium citrate which was added
as anticoagulant. The blood was then diluted with normal
saline (0.9 %) to give 2 × 107 IRBCs in an injection volume
of 0.2 ml. The amount of normal saline used in the dilu-
tion was determined by the level of parasitaemia (%) of
the infected donor mice. If 0.5 ml of blood was removed
then dilution was done with (X-0.5) ml of saline, where X
was the % parasitaemia. Each mouse was then infected by
injecting 0.2 ml of this diluted blood via IP which con-
tained 2 × 107 IRBCs, which produces a steadily rising in-
fection in mice [21, 22].
Grouping and dosing of animals
For each model (suppressive and prophylactic), twenty five
mice were grouped into five groups of five mice each.
Group I mice were treated with the vehicle (distilled water,
10 ml/kg, served as negative control), group II, III and IV
mice were treated with 100, 200, and 400 mg/kg of crude
extract, respectively and the last group (V) mice were
treated with the standard drug (chloroquine, 10 mg/kg,
served as positive control).
The safety data of the plant was obtained from Praveen et
al. [16] as the crude methanolic extract of the seeds of B.
nigra was safe at 2000 mg/kg in mice and this was a basis
for the selection of the three dose levels (100, 200 and
400 mg/kg) of the extract for the current antimalarial activ-
ity evaluation. As people traditionally use the plant material
for treatment and prevention of malaria orally [14], each
treatment was administered through oral route using oral
gavage to ensure safe ingestion of the preparations.
Four-day suppressive antimalarial test
Plasmodium berghei four-day suppressive test, the most
widely used preliminary test, in which the efficacy of four
daily doses of new compounds is measured by comparison
of blood parasitaemia and survival times of treated and
untreated mice. The test provides a preclinical indication
of potential bioactivity of the extract [21, 23]. The test was
done by a method described by Fidock et al. [21]. After
standard parasite inoculation (2 × 107 P. berghei IRBCs,
0.2 ml), 25 mice were randomly divided into five groups
with five mice each as above mentioned in grouping of an-
imals. Treatment was started three hours after infection
and then continued for three consecutive days (i.e., from
D0 to D3). On the 5th day (D4), thin blood films were
made from the tail of each mouse on a microscopic slide
(Citoplus, China).
Prophylactic antimalarial test
Compounds identified as being active in four-day sup-
pressive assays can subsequently be further examined
through the use of several secondary tests in mice from
which prophylactic test are one of them. Evaluation of
prophylactic potential of the extract was done according
to Fidock et al. [21]. Twenty five mice were randomly
grouped into five groups as mentioned above accordingly
and then treated for four consecutive days (D0 to D3). On
the fifth day (D4), a standard inoculum (2 × 10
7 P. berghei
IRBCs, 0.2 ml) was administered by IP to each mouse.
After 72 h of infection (D7), thin blood smears were pre-
pared from tail of each mouse on a microscopic slide.
Peripheral blood smear preparation
For both models (suppressive and prophylactic), thin
smears of blood were made from the tail of each mouse
on the fifth day (D4) and eighth day (D7), respectively.
The smears were applied on microscopic slides and the
bloods were drawn evenly across a second slide to make
thin blood films and allowed to dry at room temperature.
Then they were fixed with 100 % methanol and stained
with 10 % Giemsa stain at pH 7.2 for 15 min.
Parasitemia determination
Each stained slide for each mouse was examined under
microscope (Olympus, Japan). The parasitaemia was deter-
mined by counting the number of parasitized erythrocytes
in random fields of the microscope. The smears were
counted by a laboratory technician to make the reader
blind to the category. Percent parasitaemia and percent
suppression were calculated by using the following for-
mula, respectively [21, 24].
% Parasitaemia ¼ Number of infected RBCs
Total Number of RBCs
 100
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Determination of mean survival time
Mean survival time (MST) is another parameter that is
commonly used to evaluate the efficacy of antimalarial
plant extracts [25]. An extract that results in survival
time greater than that of infected non-treated mice was
considered as active. Mortality was monitored daily and
the number of the days from the time of infection up to
death was recorded for each mouse in the treatment and
control groups throughout the follow-up period and the
MST was calculated for each group by using the follow-
ing formula.
MST ¼ Sum of Survival Time of All Mice in a Group daysð Þ
Total Number of mice in That Group
Body weight determination
Body weight loss is one feature of rodent malaria infec-
tions. Body weight change is another parameter used to
assess the effectiveness of plant extracts [24]. The body
weight of each mouse in all groups was taken before in-
fection (D0) and treatment (D1) and after treatment (D4)
and infection (D7), in suppressive and prophylactic tests,
respectively. The weight of each mouse was measured using
sensitive electrical balance (ADP 720 L, Adam Equipment).
Then, % body weight change of extract treated groups was
compared with the control groups.
Data analysis
The data of the study were expressed as mean ± SEM
(standard error of mean) for each group of experiments.
Data on the levels of parasitemia, variations in body
weight and survival times were analyzed using windows
SPSS version 16.0. The differences between means of mea-
sured parameters were compared using one-way ANOVA
followed by Turkey’s HSD multiple comparison test and
paired sample t-test (two-tailed). The P values < 0.05 were
regarded as statistically significant.
Data quality control
The quality of data was assured by using randomization
during grouping of experimental animals and assignments
of treatments. Codes were used for all microscopic slides.
Parasitized RBCs were counted blindly by a laboratory
technician.
Ethical consideration
During experimental procedures, experimental animals
were handled and cared according to the internation-
ally accepted laboratory animals’ use, care and welfare
guideline [20]. Ethical clearance was requested to and
obtained from animal ethics committee of Department of
Pharmacology, School of Pharmacy, University of Gondar.
Results
Percentage yield of the plant material
The percentage yield of the dry matter of the 80 %
methanolic crude extract of the seeds of Brassica nigra
was 9.85 % w/w. Its actual yield was 32 g. It was red in
its colour. Hygroscopic powder was formed after drying.
Four-day suppressive antimalarial activity of the extract
The methanolic crude extract of the seeds of Brassica
nigra showed chemosuppressive activity against Plasmo-
dium berghei infection in mice with 21.88, 50.00 and
53.13 % chemosuppressions at 100, 200 and 400 mg/kg
of the extract, respectively, shown in Table 1.
Even though there were differences in parasitemia sup-
pression among extract treated groups, they were statis-
tically non-significant.
Chemoprophylactic antimalarial activity of the extract
The extract of Brassica nigra also showed chemoprophy-
lactic activity against Plasmodium berghei infection in
mice with 17.42, 21.21 and 53.79 % suppressions at 100,
200 and 400 mg/kg of the extract, respectively, shown in
Table 2.
Table 1 Four-day chemosuppressive activity of methanolic crude extract of the seeds of Brassica nigra against Plasmodium berghei
infection in mice
Treatments Doses % Parasitemia % Chemosuppression
Distilled water 10 ml/kg 25.60 ± 2.40 0.00
Brassica nigra seed extract 100 mg/kg 20.00 ± 2.53 21.88b3
200 mg/kg 12.80 ± 0.80 50.00a2,b2
400 mg/kg 12.00 ± 2.83 53.13a2,b1
Chloroquine 10 mg/kg 1.40 ± 0.75 94.53a3
Values are expressed as Mean ± SEM; n = 5. Where a = as compared to negative control; b = as compared to positive control; 1 = P < 0.05; 2 = P < 0.01 and 3 = P < 0.001
% Suppression ¼ % Parasitemia of Negative Control–% Parasitemia of Treated Groupð Þ
% Parasitemia of Negative Control
 100
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There were no statistically significant chemoprophylac-
tic differences among extract treated groups as that of
four-day suppressive test.
Effect of extract on survival times of mice
In the four-day suppressive test, 200 and 400 mg/kg ex-
tract treated groups lived longer than the corresponding
negative control. There were no significant differences in
survival times among extract treated groups. In prophy-
lactic test, however, the survival times did not prolonged
significantly as compared to negative control, shown in
Table 3.
Effect of extract on body weights of mice
In the 4-day suppressive test, all extract treated groups pre-
vented body weight loss as compared to negative control.
However, there were no significant differences in weight
gain among extract treated groups, shown in Table 4.
In the prophylactic test, however, there were non-
significant body weight gains in extract treated groups as
compared to negative control, shown in Table 5.
Discussion
The antimalarial activity of the crude methanolic extract
of the seeds of Brassica nigra, used in traditional medi-
cine in Ethiopia and elsewhere, against Plasmodium
berghei infection in mice in both four-day suppressive
and prophylactic test models are reported.
The percentage suppression of parasitaemia of the ex-
tract treated groups changed significantly from those in
the negative control group showing that the extract has
antimalarial activity supporting the folk use of the plant as
antimalarial herb. A compound is considered as active
when percent suppression in parasitemia is 30 % or more
[26, 27], which supports the findings of the current study.
The mice treated with 200 and 400 mg/kg of extract
showed significant 50.00 and 53.13 % chemosuppressions,
respectively, as compared to negative control. The chemo-
suppressive effects of the extract of the seeds of Brassica
nigra in the current study were in agreement with other re-
ports on medicinal plants used for malaria such as Echinops
kebericho [28]; Agelanthus dodeneifolius [29]; Sida rhombi-
folia [30] and Phytolacca dodecandra [31] which showed
significant 29.46 % and 57.29; 48.02 and 50.50; 50.10 and
52.30; and 50.93 and 55.24 % chemosuppressions, respect-
ively, with similar doses.
According to Deharo et al. [32], in vivo antimalarial
activity of plant extracts can be categorized as: moder-
ate, good and very good if the extract showed 50 % or
more chemosuppression at 500, 250 and 100 mg/kg/day
extract dose, respectively. Hence, the current finding re-
vealed that hydroalcoholic seed extract of B. nigra has
good 4-day suppressive antimalarial activity.
Table 2 Chemoprophylactic activity of methanolic crude extract of the seeds of Brassica nigra against Plasmodium berghei infection in mice
Treatments Doses % Parasitemia % Chemosuppression
Distilled water 10 ml/kg 26.40 ± 5.80 0.00
Brassica nigra seed extract 100 mg/kg 21.80 ± 2.65 17.42b2
200 mg/kg 20.80 ± 3.01 21.21b2
400 mg/kg 12.20 ± 1.36 53.79a1
Chloroquine 10 mg/kg 1.00 ± 0.45 96.21a3
Values are expressed as Mean ± SEM; n = 5. Where a = as compared to negative control; b = as compared to positive control; 1 = P < 0.05; 2 = P < 0.01 and 3 = P < 0.001
Table 3 Effect of crude methanolic extract of the seeds of B. nigra on the mean survival times of P. berghei infected mice in both
suppressive and prophylactic tests
Tests Treatments Doses Mean Survival Times (Days)
Suppressive Distilled water 10 ml/kg 7.20 ± 0.37
Brassica nigra seed extract 100 mg/kg 7.60 ± 0.25b2
200 mg/kg 9.00 ± 0.45a1,b2
400 mg/kg 9.00 ± 0.71a1,b2
Chloroquine 10 mg/kg 15.00 ± 0.00a2
Prophylactic Distilled water 10 ml/kg 6.80 ± 0.20
Brassica nigra seed extract 100 mg/kg 7.00 ± 0.32b2
200 mg/kg 7.60 ± 0.25b2
400 mg/kg 7.80 ± 0.37b2
Chloroquine 10 mg/kg 14.60 ± 0.40a2
Values are expressed as Mean ± SEM; n = 5. Where a = as compared to negative control; b = as compared to positive control; 1 = P < 0.05 and 2 = P < 0.001
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The methanolic seed extract of B. nigra also showed
significant chemoprophylactic activity against residual
infection at 400 mg/kg as 53.79 % chemosuppression.
The current finding was in agreement with other reports
on medicinal plants used for malaria such as Languas
galangal [33] and Agelanthus dodeneifolius [29] which
showed significant 52.00 and 56.00 % chemosuppression,
respectively. According to Deharo et al. [32] in vivo anti-
malarial activity classification, the methanolic crude ex-
tract of the seeds of Brassica nigra showed moderate
chemoprophylactic antimalarial activity.
In both models (suppressive and prophylactic), chloro-
quine, the current antimalarial drug, was used as a refer-
ence drug [21, 25] and it showed parasitemia suppression
near to undetectable levels of 94.53 and 96.21 %, respect-
ively. It leads to decreased parasitemia and resultant re-
covery of severe malaria by reducing parasite nutrient
intake as well as by interfering with parasite metabolic
machinery involved with iron [33]. The chemosuppression
showed by chloroquine in the current study was in agree-
ment with other studies on medicinal plants used for mal-
aria such as Artemisia annua [34], Annona senegalensis
[35] and Adhathoda schimperiana [36] which showed
90.48, 96.20 and 97.80 %, respectively.
The pharmacological (i.e., the antiplasmodial) activities
of plants are due to the presence of bioactive secondary
metabolites in the crude plant material [37]. Basically, dif-
ferent secondary metabolites, such as alkaloids, glycosides,
phenols, terpenoids and sterols [17], flavonoids and tan-
nins [18], have been reported from the seed extract of
Brassica nigra. These metabolites have antiplasmodial ac-
tivities [9, 10, 37, 38]. However, the active compound(s)
responsible for this observed antiplasmodial activity need
to be identified.
Therefore, the antiplasmodial activity observed in this
plant could have resulted from single or in combined action
of the above metabolites [39]. The possible mechanisms of
antiplasmodial activity might be through anti-oxidation and
free radical scavenging [21], immunomodulatory [35], inter-
calation in DNA, inhibition of protein synthesis, interfer-
ence with the invasion of new RBCs by parasites, or by any
other unknown mechanisms [29, 39].
Mean survival time is another parameter evaluates the
antimalarial activity of plant extracts. Accordingly, a plant
material that can prolong the survival time of infected ex-
perimental animals compared to the negative controls are
considered as active agents against malaria [25]. An ex-
tract that results in survival time greater than that of in-
fected non-treated mice was considered as active [27]. In
this study the mice treated with 200 and 400 mg of extract
had significantly lived longer than negative control in
four-day suppressive test. This might be due to the anti-
plasmodial activity of the extract. However, the survival
times of mice treated with the extract were shorter as
compared to positive control; this might be the fast
elimination phase of the extract. The current findings
were in agreement with studies done on medicinal plants
used for malaria such as Dodonaea angustifolia [40] and
Nigella sativa [41].
Body weight loss is one manifestation of Plasmodium
berghei-infected mice. This is due to the depressant ac-
tion on the appetite of the mice and the consequences
of disturbed metabolic function and hypoglycemic effect
of the parasite [22]. Body weight change of mice is also
Table 4 Effect of crude methanolic extract of the seeds of B. nigra on the body weights of P. berghei infected mice in suppressive test
Treatments Doses Body Weight (gm)
D0-Weight D4-Weight Wt Change (%)
Distilled water 10 ml/kg 29.64 ± 0.34 29.30 ± 0.32 −1.15
Brassica nigra seed extract 100 mg/kg 30.38 ± 1.89 30.48 ± 2.05 0.33
200 mg/kg 26.68 ± 1.57 26.92 ± 1.57 0.90a1
400 mg/kg 29.26 ± 1.41 29.62 ± 1.42 1.23a1
Chloroquine 10 mg/kg 28.18 ± 1.64 28.58 ± 1.65 1.42a2
Values are expressed as Mean ± SEM; n = 5. Where a = as compared to negative control; 1 = P < 0.01 and 2 = P < 0.001
Table 5 Effect of crude methanolic extract of the seeds of B. nigra on the body weights of P. berghei infected mice in prophylactic test
Treatments Doses Body Weight (gm)
D1-Weight D7-Weight Wt Change (%)
Distilled water 10 ml/kg 24.94 ± 1.99 24.48 ± 2.00 −1.84
Brassica nigra seed extract 100 mg/kg 26.80 ± 0.99 27.00 ± 0.94 0.75
200 mg/kg 25.84 ± 2.42 26.06 ± 2.50 0.85
400 mg/kg 28.10 ± 1.56 28.42 ± 1.68 1.14
Chloroquine 10 mg/kg 26.86 ± 1.13 27.34 ± 1.17 1.79a1
Values are expressed as Mean ± SEM; n = 5. Where a = as compared to negative control and 1 = P < 0.05
Muluye et al. BMC Complementary and Alternative Medicine  (2015) 15:367 Page 6 of 8
another parameter that evaluates the antimalarial activity of
plant extracts [42]. Mice treated with 200 and 400 mg/kg of
extract showed a significant increased in body weight gain
as compared to negative control, hence, this might tell us
the antiplasmodial activity of the extract.
The plant possesses other pharmacologic benefits which
might in part lead to increased weight gain including appe-
tite stimulant activity [12] and it is nutritionally endowed
with vitamin Bs such as vitamin B1, thiamine which main-
tains appetite and growth; vitamin B2, riboflavin which pre-
vents skin lesions and weight loss; and vitamin B3, niacin
which maintains the normal function of the nervous system
and the gastrointestinal tract [13]. However, the weight
gains of extract treated mice were insignificant as compared
to the negative control in prophylactic test. This might be
the rapid hepatic clearance of the active component of the
plant, which was given before infection at which the basal
metabolic rate of the mice is active, involved in weight gain.
This finding was in agreement with other study on medi-
cinal plant, Faidherbia albida [43], used for malaria.
Conclusion
From this study, it can be concluded that the seeds of
Brassica nigra showed good chemosuppressive and
moderate chemoprophylactic antimalarial activities
against Plasmodium berghei infection in mice. Accord-
ingly, with the essence of further studies this plant
could serve as the potential source of new and novel anti-
malarial leads and/or drugs for the treatment and preven-
tion of malaria.
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